Preventive Cardiology and Preventive Medicine, Center for Cardiology.
Center for Thrombosis and Hemostasis (CTH), and.
Blood. 2021 May 13;137(19):2681-2693. doi: 10.1182/blood.2019004571.
Patients with isolated pulmonary embolism (PE) have a distinct clinical profile from those with deep vein thrombosis (DVT)-associated PE, with more pulmonary conditions and atherosclerosis. These findings suggest a distinct molecular pathophysiology and the potential involvement of alternative pathways in isolated PE. To test this hypothesis, data from 532 individuals from the Genotyping and Molecular Phenotyping of Venous ThromboEmbolism Project, a multicenter prospective cohort study with extensive biobanking, were analyzed. Targeted, high-throughput proteomics, machine learning, and bioinformatic methods were applied to contrast the acute-phase plasma proteomes of isolated PE patients (n = 96) against those of patients with DVT-associated PE (n = 276) or isolated DVT (n = 160). This resulted in the identification of shared molecular processes between PE phenotypes, as well as an isolated PE-specific protein signature. Shared processes included upregulation of inflammation, response to oxidative stress, and the loss of pulmonary surfactant. The isolated PE-specific signature consisted of 5 proteins: interferon-γ, glial cell line-derived neurotrophic growth factor, polypeptide N-acetylgalactosaminyltransferase 3, peptidyl arginine deiminase type-2, and interleukin-15 receptor subunit α. These proteins were orthogonally validated using cis protein quantitative trait loci. External replication in an independent population-based cohort (n = 5778) further validated the proteomic results and showed that they were prognostic for incident primary isolated PE in individuals without history of VTE (median time to event: 2.9 years; interquartile range: 1.6-4.2 years), supporting their possible involvement in the early pathogenesis. This study has identified molecular overlaps and differences between VTE phenotypes. In particular, the results implicate noncanonical pathways more commonly associated with respiratory and atherosclerotic disease in the acute pathophysiology of isolated PE.
患有孤立性肺栓塞 (PE) 的患者与伴有深静脉血栓形成 (DVT) 的 PE 患者具有明显不同的临床特征,前者更易出现肺部疾病和动脉粥样硬化。这些发现提示存在独特的分子病理生理学机制,以及替代性通路可能参与孤立性 PE 的发病过程。为了验证这一假说,我们对来自静脉血栓栓塞症基因分型和分子表型项目(一项多中心前瞻性队列研究,有广泛的生物样本库)的 532 名个体的数据进行了分析。应用靶向、高通量蛋白质组学、机器学习和生物信息学方法,对 96 例孤立性 PE 患者(病例组)、276 例伴有 DVT 的 PE 患者(DVT-PE 组)和 160 例孤立性 DVT 患者(DVT 组)的急性期血浆蛋白质组进行对比。这一方法鉴定出了 PE 表型之间存在的共同分子过程,以及孤立性 PE 特异性蛋白特征。共同过程包括炎症反应上调、对氧化应激的反应以及肺表面活性剂丢失。孤立性 PE 特异性特征由 5 种蛋白组成:干扰素-γ、胶质细胞源性神经营养因子、多肽 N-乙酰半乳糖胺基转移酶 3、肽基精氨酸脱亚氨酶 2 和白细胞介素 15 受体亚基 α。这些蛋白使用顺式蛋白质数量性状基因座进行了正交验证。在一个独立的基于人群的队列(n=5778)中进行的外部验证进一步验证了蛋白质组学结果,并表明它们对无 VTE 病史个体新发孤立性 PE 具有预后价值(中位事件时间:2.9 年;四分位间距:1.6-4.2 年),这支持了它们可能参与早期发病机制的假设。本研究鉴定了 VTE 表型之间的分子重叠和差异。特别是,结果提示非典型通路与呼吸和动脉粥样硬化疾病的关系更为密切,这些通路可能参与了孤立性 PE 的急性病理生理学过程。